Related Experiment Video
Updated: Mar 9, 2026
06:18
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
Published on: August 18, 2023
3.9K
Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design
Yonatan Y Lipsitz1, Patrick Bedford2, Anthony H Davies3
1Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada.
Cell Stem Cell
|January 7, 2017
Summary
New gene and cell manipulation methods engineer cell functionality and manufacturability. These advances address cell therapy manufacturing challenges, improving patient access to living therapeutics.
Area of Science:
- Biotechnology
- Cellular Engineering
- Therapeutic Development
Background:
- Cell therapy manufacturing faces significant challenges impacting scalability and accessibility.
- Current quality assessment and engineering methods are insufficient for complex cellular systems.
Purpose of the Study:
- To introduce novel methods for manipulating gene and cell states.
- To enhance cell functionality, quality assessment, and manufacturability in cell therapies.
- To address key obstacles in the production of living therapeutics.
Main Methods:
- Development of advanced gene manipulation techniques.
- Implementation of novel cell state control strategies.
- Integration of quality assessment and manufacturing process improvements.
Main Results:
- Engineered cell functionality demonstrated through successful manipulation.
- Simplified and more robust quality assessment protocols.
- Enhanced manufacturability leading to improved production efficiency.
Conclusions:
- Novel gene and cell manipulation methods offer solutions to cell therapy manufacturing challenges.
- These strategies facilitate the design of quality into cellular systems.
- Successful implementation will increase patient access to life-changing living therapeutics.
